Evidence for a Conserved Metabolic Architecture of Cellular Senescence Across Neurodegenerative Diseases: A Systematic Review
Metabolites · 16.11.2026 · 16 (11) · 896
DOI: 10.3390/metabo16110896 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Metabolites, online erschienen am 16.11.2026. Verfasst von Davie L. Slocum und 3 weiteren Autor:innen. Die Arbeit nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cellular senescence contributes to neurodegenerative disease through chronic inflammatory signaling, mitochondrial dysfunction, and metabolic remodeling. Although metabolomic studies have identified numerous metabolic abnormalities in neurodegeneration, their relationship with cellular senescence has not been systematically evaluated.
Methods
This systematic review followed PRISMA 2020 guidelines. An artificial intelligence-assisted semantic search using Elicit was supplemented by investigator-led screening and additional PubMed and Embase searches. Twenty-three peer-reviewed studies met predefined eligibility criteria. Data were verified against the original publications and synthesized qualitatively according to recurring metabolic pathways and senescence-associated mechanisms.
Results
Four recurrent metabolic themes emerged: (1) disruption of NAD+ homeostasis, purine/nucleotide, and redox metabolism; (2) mitochondrial dysfunction and glycolytic reprogramming; (3) lipid remodeling, including cholesterol, oxysterol, sphingolipid, and lipid-droplet dysregulation; and (4) circulating metabolic signatures with potential translational relevance. These alterations repeatedly converged on senescence-associated features including oxidative stress, mitochondrial dysfunction, chronic inflammatory signaling, and activation of p16INK4a-, p21Cip1-, and SASP-related pathways. In preclinical models, interventions targeting NAD+ metabolism, mitochondrial function, lipid homeostasis, autophagy, or senescent cells attenuated senescence-associated phenotypes and improved metabolic homeostasis.
Conclusions
Current evidence supports a close association between metabolic remodeling and cellular senescence in neurodegenerative disease. Rather than a single senescence-specific metabolite, coordinated alterations across interconnected metabolic networks appear to provide more informative indicators of the senescent phenotype. Integrated multi-omic approaches may therefore improve biomarker development and identify metabolism-based therapeutic strategies, although methodological heterogeneity and limited longitudinal human data remain important barriers to clinical translation.
Zitieren
APA
Slocum, D. L., Duka, D., Antonelli, L., & Logan, R. (2026). Evidence for a Conserved Metabolic Architecture of Cellular Senescence Across Neurodegenerative Diseases: A Systematic Review. Metabolites, 16(11), 896. https://doi.org/10.3390/metabo16110896
Vancouver
Slocum DL, Duka D, Antonelli L, Logan R. Evidence for a Conserved Metabolic Architecture of Cellular Senescence Across Neurodegenerative Diseases: A Systematic Review. Metabolites. 2026;16(11):896. doi:10.3390/metabo16110896
BibTeX
@article{Slocum2026,
author = {Slocum, Davie L. and Duka, Danja and Antonelli, Lola and Logan, Robert},
title = {Evidence for a Conserved Metabolic Architecture of Cellular Senescence Across Neurodegenerative Diseases: A Systematic Review},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {11},
pages = {896},
doi = {10.3390/metabo16110896}
}
EUVIMED